|
Foreign Attorney
| TEL |
+82-2-6386-0702 |
| E-MAIL |
sangwon.koo@leeko.com |
|
|
Sang Won (Sang) Koo is a foreign attorney in the Corporate and Mergers and Acquisitions Group of Lee & Ko. Mr. Koo advises Korean and global clients, including many of the largest Korean conglomerates, on cross-border M&A transactions, investments, strategic alliances and joint ventures. Prior to joining Lee & Ko, Mr. Koo worked at leading U.S. and U.K. law firms in New York, London and Seoul.
学历
| 2020 |
Georgetown University Law Center – J.D. |
| 2015 |
Georgetown University – B.S., Culture and Politics |
经历
| 2025-Present |
Lee & Ko |
| 2023-2025 |
Ashurst Korea JV |
| 2021-2023 |
Baker & McKenzie LLP, London |
| 2020-2021 |
Greenberg Traurig, LLP, New York |
主要业务方向
| 企业并购 |
| 企业咨询 |
| 企业治理结构 |
| 外商投资 |
| 境外投资 |
资格/会员
| Admitted to the New York State Bar (2021) |
语言
主要业绩
- Advised Celltrion on its asset sale of pharmaceutical products and over-the-counter products in Asia Pacific region
- Advised Celltrion on its acquisition of iQone Healthcare based in Switzerland
- Advised SK Telecom on its joint venture with Deutsche Telekom, e& Group, Singtel and SoftBank Corp. to develop Large Language Models (LLM) specifically for telecommunications companies.
- Advised SK earthon in connection with its divestiture of minority stake in an LNG manufacturer to EIG Partners
- Advised SK Telecom on its strategic investment in Lambda, a cloud-based GPU company in the U.S.
- Advised Kama Al Mana on its acquisition of McDonald’s Korea
- Advised a Middle Eastern petrochemical company on its acquisition of a Korean company
- Advised a European petrochemical company on its investment in a Korean company
- Advised a Southeast Asian entertainment company on its convertible bond investment in a Korean company
- Advised Emerson on the US$14 billion sale of its Climate Technologies business
- Represented the syndicate of 10 underwriters in connection with Teva Pharmaceutical’s US$5 billion high-yield bond offering
- Represented the syndicate of 10 lenders in connection with Teva Pharmaceutical’s US$1.8 billion revolving credit facility
- Represented the initial purchasers in connection with Liberty Costa Rica’s financing transactions
- Advised Goldman Sachs, Morgan Stanley, D and Z Media Acquisition, and other clients on multiple U.S. SPAC IPO transactions